-----Original Message-----
From: Antibody Discussion Forum <email obscured>> On Behalf Of
Bover,Laura
Sent: Thursday, July 30, 2020 9:38 AM
To: <email obscured>
Subject: Re: [ABRF Ab Forum] [EXT] Subtractive Immunization
[External Email]
Yes, please propose several times or later I send you my available ! Great!
Laura Bover, PhD
Professor
Director Monoclonal Antibody Core Facility University of Texas M.D.Anderson
Cancer Center Associate member of The University of Texas Graduate School of
Biomedical Sciences at Houston Member of the Scientific Review Committee 2
(former CRC 2) Member of the Steering Committee of the Immunology Program GSBS
Immunology Department/ Genomics Medicine Department
7455 Fannin St<x-apple-data-detectors://1/1> Room 1SCR4.2021
Houston- TX 77054<x-apple-data-detectors://2/0>
T 713-563-3301<tel:713-563-3301>
F 713-563-3276<tel:713-563-3276>
<email obscured><email obscured>>
On Jul 30, 2020, at 7:53 AM, <email obscured>" <email obscured>> wrote:
WARNING: This email originated from outside of MD Anderson. Please validate
the sender's email address before clicking on links or attachments as they may
not be safe.
Ed and Laura
Can we set up a time learn about subtractive immunization early next week?
In the mean time I’ll or the cyclophosphamide.
ARG Discussion Forum Members,
Does anyone else want to attend?
Frances
Frances Weis-Garcia, Ph.D.
Head
Bi-Institutional Antibody and Bioresource Core Facility
Associate Laboratory Member
Immunology Program
Memorial Sloan Kettering Cancer Center
1275 York Avenue, New York, NY 10065
T 646.888.2354 C 516.967.0656
ABCF-MSKCC
website<https://urldefense.com/v3/__https://www.mskcc.org/research-advantage/core-facilities/monoclonal-antibody-core-facility__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQavGbEqZ$
>
Adjunct Faculty
Center for Clinical and Translational Science
The Rockefeller University
1230 York Avenue, New York, NY 10065
T 212.327.7030
ABCF-RU
website<https://urldefense.com/v3/__https://www.rockefeller.edu/monoclonal/__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQStlvFdx$
>
Please note that this e-mail and any files transmitted with it may be
privileged, confidential, and protected from disclosure under applicable law.
If the reader of this message is not the intended recipient, or an employee or
agent responsible for delivering this message to the intended recipient, you
are hereby notified that any reading, dissemination, distribution, copying, or
other use of this communication or any of its attachments is strictly
prohibited. If you have received this communication in error, please notify
the sender immediately by replying to this message and deleting this message,
any attachments, and all copies and backups from your computer.
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan Kettering Cancer Center may be privileged, confidential,
and protected from disclosure under applicable law. If the reader of
this message is not the intended recipient, or an employee or agent
responsible for delivering this message to the intended recipient,
you are hereby notified that any reading, dissemination, distribution,
copying, or other use of this communication or any of its attachments
is strictly prohibited. If you have received this communication in
error, please notify the sender immediately by replying to this message
and deleting this message, any attachments, and all copies and backups
from your computer.
――
View topic
https://urldefense.com/v3/__http://list.abrf.org/r/topic/UGk03QWN9LUZhf49lemWo__;!!PfbeBCCAmug!wVUFEDGZknG4iLngHzB3DVUQXfsU6doiBiI0jvvegef4wgmYdnvM0bvZQUrtoCZq$
Leave group <email obscured>?Subject=Unsubscribe
The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.
――
View topic
https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_2Ah9zjtxUijOERBGsq2mML&d=DwIFaQ&c=sJ6xIWYx-zLMB3EPkvcnVg&r=F6AO--4VYeLfDWXyalUQRQ&m=4iz1voPUApsW7XoXCeDbHEh3oVdv-G37GcJDCaOxbeA&s=hhSVRO1MsAk0UvQzbLnmFWUuZ96ZXVu_Rv1ybRTQqnM&e=
Leave group <email obscured>?Subject=Unsubscribe
